Hey, sorry about your dad, I hope he is doing ok.
For obvious reasons I'm not going to give medical advice over the internet, and I assume if he's in any major Australian hospital he's got multiple teams of experts taking care of each issue he has.
That's a complex, and reasonably common scenario. Treating the infection is going to be the most important thing at the moment, so IV antibiotics will be step one - for cellulitis we often do fluclox or cefazolin but it depends on a number of things, and if a patient has ever had MRSA in the past I would be giving them vanc - again, tricky, as vanc needs to be renally adjusted and monitored closely.
For the fluid that's a tricky one as well - peripheral oedema has a number of causes, and the infection both thrives in it and makes it worse. If it's due to the heart failure, and I'm assuming that is playing a role, they're likely trying to get that fluid off with lasix - though again, they'd need to monitor the kidneys and electrolytes closely.
Withholding certain meds, regular bloods, appropriate disposition (ICU, HDU, CCU, etc), imaging, etc all play a role as well.
These are all broad generalisations (simply things I would be considering in Emergency) as I don't know your dad, his background, his LVEF, his meds, and I certainly am not going to give any medical advice online.
Its a tough situation and it hope he does well. I'm sure he is in good hands.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-194
-
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.065(6.07%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
$1.05 | $1.05 | 99.5¢ | $9.449M | 9.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 64541 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 1.005 |
7 | 58759 | 1.000 |
13 | 162397 | 0.995 |
23 | 402743 | 0.990 |
10 | 194198 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 64541 | 3 |
1.025 | 71041 | 4 |
1.030 | 154979 | 5 |
1.035 | 90341 | 5 |
1.040 | 32541 | 1 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online